Advanced cancer therapy shows promising results in licensing agreement announcement |Michael Baker, CEO, Arovella Therapeutics Ltd. 00:10:00
The interview features the CEO discussing the company's recent licensing agreement with the University of North Carolina's Lineberger Comprehensive Cancer Center, highlighting the potential benefits of incorporating new technology into their cancer therapy platform, along with insights into the company's future plans for clinical trials and product development.